Profile | GDS5420 / 208686_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1048.08 | 80 |
GSM1296119 | B_lesional_pre-dose | 725.49 | 74 |
GSM1296076 | C_lesional_pre-dose | 740.09 | 75 |
GSM1296092 | D_lesional_pre-dose | 864.91 | 76 |
GSM1296103 | E_lesional_pre-dose | 1048.14 | 80 |
GSM1296078 | F_lesional_pre-dose | 397.23 | 65 |
GSM1296107 | G_lesional_pre-dose | 749.25 | 75 |
GSM1296109 | H_lesional_pre-dose | 749.21 | 74 |
GSM1296080 | I_lesional_pre-dose | 1091.35 | 80 |
GSM1296090 | J_lesional_pre-dose | 820.54 | 76 |
GSM1296074 | K_lesional_pre-dose | 747.28 | 75 |
GSM1296111 | L_lesional_pre-dose | 842.37 | 77 |
GSM1296099 | M_lesional_pre-dose | 997.24 | 79 |
GSM1296086 | O_lesional_pre-dose | 743.46 | 74 |
GSM1296117 | P_lesional_pre-dose | 1034.91 | 80 |
GSM1296113 | Q_lesional_pre-dose | 1010.74 | 80 |
GSM1296096 | R_lesional_pre-dose | 944.78 | 78 |
GSM1296105 | S_lesional_pre-dose | 633.78 | 71 |
GSM1296098 | T_lesional_pre-dose | 968.3 | 79 |
GSM1296101 | U_lesional_pre-dose | 922.57 | 78 |
GSM1296121 | V_lesional_pre-dose | 930.82 | 78 |
GSM1296088 | W_lesional_pre-dose | 953.38 | 78 |
GSM1296082 | X_lesional_pre-dose | 808.79 | 76 |
GSM1296115 | Y_lesional_pre-dose | 948 | 78 |
GSM1296084 | Z_lesional_pre-dose | 671.41 | 73 |
GSM1296072 | B_lesional_day8 | 849.19 | 77 |
GSM1296069 | L_lesional_day8 | 652.3 | 72 |
GSM1296071 | P_lesional_day8 | 949.79 | 79 |
GSM1296070 | Y_lesional_day8 | 626.91 | 71 |
GSM1296073 | V_lesional_day8 | 728.43 | 74 |
GSM1296034 | A_lesional_day15 | 909.73 | 77 |
GSM1296041 | G_lesional_day15 | 747.99 | 75 |
GSM1296035 | R_lesional_day15 | 1020.78 | 79 |
GSM1296038 | U_lesional_day15 | 682.99 | 73 |
GSM1296047 | B_lesional_day15 | 584.77 | 70 |
GSM1296039 | E_lesional_day15 | 922.4 | 78 |
GSM1296042 | H_lesional_day15 | 672.88 | 73 |
GSM1296043 | L_lesional_day15 | 811.87 | 76 |
GSM1296037 | M_lesional_day15 | 798.01 | 75 |
GSM1296046 | P_lesional_day15 | 694.07 | 73 |
GSM1296044 | Q_lesional_day15 | 899.16 | 78 |
GSM1296045 | Y_lesional_day15 | 815.25 | 76 |
GSM1296025 | C_lesional_day15 | 523.17 | 68 |
GSM1296033 | D_lesional_day15 | 843.19 | 76 |
GSM1296027 | I_lesional_day15 | 519.11 | 69 |
GSM1296032 | J_lesional_day15 | 612.45 | 71 |
GSM1296024 | K_lesional_day15 | 741.2 | 74 |
GSM1296031 | W_lesional_day15 | 636.65 | 71 |
GSM1296028 | X_lesional_day15 | 738.09 | 74 |
GSM1296029 | Z_lesional_day15 | 580.15 | 70 |
GSM1296026 | F_lesional_day15 | 398.53 | 64 |
GSM1296030 | O_lesional_day15 | 718.15 | 73 |
GSM1296040 | S_lesional_day15 | 651.23 | 72 |
GSM1296036 | T_lesional_day15 | 1298.34 | 83 |
GSM1296048 | V_lesional_day15 | 879.95 | 77 |
GSM1296059 | A_lesional_day43 | 890.72 | 77 |
GSM1296066 | G_lesional_day43 | 709.55 | 74 |
GSM1296060 | R_lesional_day43 | 968.45 | 78 |
GSM1296063 | U_lesional_day43 | 614.78 | 71 |
GSM1296064 | E_lesional_day43 | 654.7 | 73 |
GSM1296067 | H_lesional_day43 | 611.82 | 71 |
GSM1296062 | M_lesional_day43 | 1088.1 | 80 |
GSM1296068 | Q_lesional_day43 | 831.96 | 76 |
GSM1296050 | C_lesional_day43 | 790 | 75 |
GSM1296057 | D_lesional_day43 | 941.37 | 78 |
GSM1296052 | I_lesional_day43 | 472.85 | 67 |
GSM1296054 | J_lesional_day43 | 646.51 | 72 |
GSM1296049 | K_lesional_day43 | 826.81 | 76 |
GSM1296055 | W_lesional_day43 | 714.88 | 73 |
GSM1296053 | X_lesional_day43 | 607.11 | 70 |
GSM1296058 | Z_lesional_day43 | 464.61 | 66 |
GSM1296051 | F_lesional_day43 | 707.14 | 74 |
GSM1296056 | O_lesional_day43 | 882.53 | 77 |
GSM1296065 | S_lesional_day43 | 563.47 | 70 |
GSM1296061 | T_lesional_day43 | 1289.77 | 83 |
GSM1296095 | A_non-lesional_pre-dose | 872.84 | 77 |
GSM1296120 | B_non-lesional_pre-dose | 692.99 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 699.61 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 820.8 | 76 |
GSM1296104 | E_non-lesional_pre-dose | 628.38 | 72 |
GSM1296079 | F_non-lesional_pre-dose | 757 | 75 |
GSM1296108 | G_non-lesional_pre-dose | 544.99 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 657.58 | 72 |
GSM1296081 | I_non-lesional_pre-dose | 251.75 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 830.99 | 76 |
GSM1296075 | K_non-lesional_pre-dose | 558.89 | 70 |
GSM1296112 | L_non-lesional_pre-dose | 765.19 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 876.11 | 77 |
GSM1296087 | O_non-lesional_pre-dose | 288.71 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 612.33 | 71 |
GSM1296114 | Q_non-lesional_pre-dose | 962.1 | 79 |
GSM1296097 | R_non-lesional_pre-dose | 824.89 | 76 |
GSM1296106 | S_non-lesional_pre-dose | 780.17 | 75 |
GSM1296102 | U_non-lesional_pre-dose | 818.34 | 76 |
GSM1296122 | V_non-lesional_pre-dose | 580.94 | 70 |
GSM1296089 | W_non-lesional_pre-dose | 815.55 | 76 |
GSM1296083 | X_non-lesional_pre-dose | 738.43 | 74 |
GSM1296116 | Y_non-lesional_pre-dose | 734.19 | 74 |
GSM1296085 | Z_non-lesional_pre-dose | 552.24 | 69 |